Xeris Biopharma Holdings Inc. reports a 24% revenue increase in 2024, surpassing $203 million, highlighting significant growth....
Investors experienced a brief calm despite U.S. trade policy shake-ups and global borrowing cost increases. Bonds found...
Domo concluded fiscal year 2025 with strong accomplishments, highlighted by a notable gap reduction between billings and...
Traeger reported a 3% revenue increase for Q4 2024, driven by strong performance in grill and consumables...
Costco achieved a net income of $1.788 billion in Q2 2025, representing an 8.4% increase in earnings...
Amid market turbulence, cash-rich small-cap stocks present opportunities for adventurous investors, exemplified by companies like LiveRamp Holdings...
Small-cap stocks have experienced a 10% decline since November, outperforming the larger-cap S&P index, which only saw...
Energy sector transformation is driven by the shift towards renewables, despite its reduced stock market share since...
Wall Street experienced significant volatility, with the Nasdaq Composite dropping 2.61%, marking a correction in tech stocks....
Olverembatinib, a third-generation BCR-ABL inhibitor, represents a significant advancement in treating chronic myeloid leukemia (CML) and Ph+...
